Back

Molecular mechanisms of uric acid transport by the native human URAT1 and its inhibition by anti-gout drugs

Wu, C.; Zhang, C.; Jin, S.; Wang, J. J.; Dai, A.; Xu, J.; Zhang, H.; Yang, X.; He, X.; Yuan, Q.; Hu, W.; Xu, Y.; Wang, M.-W.; Jiang, Y.; Yang, D.; Xu, H. E.

2024-09-11 biochemistry
10.1101/2024.09.11.612394 bioRxiv
Show abstract

Gout, a common and painful disease, stems from hyperuricemia, where elevated blood uric acid levels lead to urate crystal formation in joints and kidneys. The human urate transporter 1 (hURAT1) plays a critical role in urate homeostasis by facilitating urate reabsorption in the renal proximal tubule, making it a key target for gout therapy. Pharmacological inhibition of hURAT1 with drugs such as dotinurad, benzbromarone, lesinurad, and verinurad promotes uric acid excretion and alleviates gout symptoms. Here we present cryo-electron microscopy structures of native hURAT1 bound with these anti-gout drugs in the inward-open state, and with uric acid in inward-open, outward-open, and occluded states. Complemented by mutagenesis and cell-based assays, these structures reveal the mechanisms of uric acid reabsorption and hURAT1 inhibition. Our findings elucidate the molecular basis of uric acid transport and anti-gout medication action, and provide a structural framework for the rational design of next-generation therapies for hyperuricemia and gout.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.